Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
18–100
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Physicians must be actively involved in the treatment/management of patients with MS
Consult with a minimum of 16 MS patients (\>5 in Japan and China, \>10 in Brazil) per month
Patients for whom physicians complete a Physician Completed Patient Record Form (PRF), and therefore are included in the pool of data for analysis, are based on the following criteria:
Patients who had a physician-made diagnosis of MS before or at the time of data collection
Patients must not currently be involved in a clinical trial
Patients ≥18 years old
For patients included in the ofatumumab sample, they must have been receiving ofatumumab for \>12 months at the time of data collection
You may not be if
None
Clareo Health | A Study to Evaluate the Real-world Experience and Satisfaction Associated With Ofatumumab
